Adding pirfenidone to mycophenolate mofetil shows no significant improvement in lung function compared with mycophenolate ...

Dr Pradeep highlights warning signs of heart failure, including increased urination at night, swollen ankles, and breathlessness.

The Food and Drug Administration (FDA) has granted traditional approval to Imdelltra ® (tarlatamab-dlle) for the treatment of adults with extensive stage small cell lung cancer (ES-SCLC) with disease ...

U.S. and Canada transaction supports continued access to RADICAVA® for people living with ALS while enabling Tanabe Pharma America to focus on future ...

U.S. and Canada transaction supports continued access to RADICAVA(R) for people living with ALS while enabling Tanabe Pharma America to focus on future growth and innovation JERSEY CITY, N.J., Dec. 22 ...

MYQORZO, a Cardiac Myosin Inhibitor, Directly Addresses Underlying Hypercontractility Associated with Obstructive HCM ...

Delhi is once again facing a severe air pollution emergency, with a thick layer of smog making it almost impossible to be ...

Men and women with emphysema benefit from endoscopic lung volume reduction (ELVR), but women may have better symptom response and QoL.

Adult patients with CAP in a low-resource setting who were treated with adjunctive low-dose glucocorticoids had a lower risk of death.

Tolmar, Inc. (Tolmar) today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for Rubraca® (rucaparib), enabling its use prior to chemotherapy for eligible ...

MYQORZO, a Cardiac Myosin Inhibitor, Directly Addresses Underlying Hypercontractility Associated with Obstructive HCM FDA Approval Based on Results of SEQUOIA-HCM MYQORZO is Company's First FDA-Approv ...

PADCEV plus Keytruda is the first and only regimen without platinum-based chemotherapy to improve event-free and overall survival when used before and after surgery ...